Reported 11 months ago
After weeks of disputes, Taiwan's Legislature passed the Regenerative Medicine Act unanimously in just two hours. The new law provides a final chance of cure for over 5 million Taiwanese patients with conditions like cancer, diabetes, and joint diseases that standard treatments have been unsuccessful in treating. The law aims to allow regenerative therapy to be used in treating diseases and reconstructing body tissues, offering hope for many patients. The law underwent revisions addressing concerns like the need for clinical trial verification and the potential for misuse by medical institutions or profit-driven practices, ultimately gaining bipartisan support and opening new opportunities for Taiwan's biotechnology industry to compete globally.
Source: YAHOO